分化拮抗非蛋白质编码RNA(DANCR)在常见恶性肿瘤中的研究进展

doi:10.11904/j.issn.1002-3070.2020.01.013

摘要/Abstract

摘要： 据GLOBOCAN 2018估计,肺癌、乳腺癌、结直肠癌、胃癌和肝癌五种癌症占2018年全球新发恶性肿瘤病例的43%左右。越来越多的研究表明,分化拮抗非蛋白质编码RNA(DANCR)在人类多种癌症中表达异常,其异常表达使癌细胞增殖和侵袭,进而促进肿瘤进展。同时,DANCR的表达水平与肿瘤的组织学分级以及患者的预后显著相关,因此将DANCR做为多种癌症的潜在生物标志物。本文通过对长链非编码RNA(lncRNA)DANCR在肺癌、乳腺癌、结直肠癌、肝癌和胃癌等常见恶性肿瘤中的研究进展做一系统综述,以阐释lncRNA DANCR在恶性肿瘤中的分子机制和临床意义。

关键词: 长链非编码RNA, DANCR, 肿瘤, 分子标志物, 研究进展

Abstract: According to GLOBOCAN 2018,lung cancer,breast cancer,colorectal cancer,gastric cancer and liver cancer account for about 43% of new global malignant tumors in 2018.A growing number of studies have shown that differentially antagonizing non-protein-encoding RNA(lncRNA-DANCR)is abnormally expressed in a variety of human cancers,and its aberrant expression promotes tumor progression by improving cancer cell proliferation and invasion.At the same time,the expression level of DANCR is significantly correlated with the histological grade of tumor and the prognosis of patient,making DANCR as a potential biomarker for a variety of cancers.This paper systematically reviews the research progress of lncRNA DANCR in common malignant tumors such as lung cancer,breast cancer,colorectal cancer,gastric cancer and liver cancer,in order to explain the molecular mechanisms and clinical significance of lncRNA DANCR in malignant tumors.

Key words: Long non-coding RNA, DANCR, Tumor, Molecular markers, Research progress

中图分类号:

郭永东, 靳晶, 李利敏, 贺宇彤. 分化拮抗非蛋白质编码RNA(DANCR)在常见恶性肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2020, 34(1): 69-73.

GUO Yongdong, JIN Jing, LI Limin, HE Yutong. Progress in differentiation of non-protein-encoding RNA(DANCR)in common malignant tumors[J]. Journal of Practical Oncology, 2020, 34(1): 69-73.

参考文献

1 Bray F,Ferly J,Soerjomataram IS,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
2 Hojman P,Gehl J,Christensen JF,et al.Molecular mechanisms linking exercise to cancer prevention and treatment[J].Cell Metal,2018,27(1):10-21.
3 Vineis P,Wild CP.Global cancer patterns:causes and prevention[J].Lancet,2014,383(9916):549-557.
4 Ellis L,Woods LM,Esteve J,et al.Cancer incidence,survival and mortality:explaining the concepts[J].Int J Cancer,2014,135(8):1774-1782.
5 Derrien T,Johnson R,Bussotti G,et al.The GENCODE v7 catalog of human long noncoding RNAs:analysis of their gene structure,evolution,and expression[J].Genome Res,2012,22(9):1775-1789.
6 Mercer TR,Dinger ME,Mattick JS.Long non-coding RNAs:insights into functions[J].Nat Rev Genet,2009,10(3):155-159.
7 Engreitz JM,Ollikainen N,Guttman M.Long non-coding RNAs:spatial amplifiers that control nuclear structure and gene expression[J].Nat Rev Mol Cell Biol,2016,17(12):756-770.
8 Knoll M,Lodish HF,Sun L.Long non-coding RNAs as regulators of the endocrine system[J].Nat Rev Endocrinol,2015,11(3):151-160.
9 Lennox KA,Behlke MA.Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides[J].Nucleic Acids Res,2016,44(2):863-877.
10 Kretz M,Webster DE,Flockhart RJ,et al.Suppression of progenitor differentiation requires the long noncoding RNA ANCR[J].Genes Development,2012,26(4):338-343.
11 Tang Z,Li C,Kang B,et al.GEPIA:a web server for cancer and normal gene expression profiling and interactive analyses[J].Nucleic Acids Res,2017,36(4):98-102.
12 Wen X,Liu X,Mao YP,et al.Long non-coding RNA DANCR stabilizes HIF-1α and promotes metastasis by interacting with NF90/NF45 complex in nasopharyngeal carcinoma[J].Theranostics,2018,8(20):5676-5689.
13 Zhang X,Yang J,Bian Z,et al.Long noncoding RNA DANCR promotes nasopharyngeal carcinoma progression by interacting with STAT3,enhancing IL-6/JAK1/STAT3 signaling[J].Biomedicine Pharmacotherapy,2019,7(20):113-120.
14 Hao YZ,Hui J,He XJ,et al.Long non-coding RNA DANCR promotes nasopharyngeal carcinoma cell proliferation and migration[J].Mol Med Rep,2019,19(4):2883-2889.
15 Lu QC,Rui ZH,Guo ZL,et al.LncRNA-DANCR contributes to lung adenocarcinoma progression by sponging miR-496 to modulate mTOR expression[J].J Cell Mol Med,2018,22(3):1527-1537.
16 Wang S,Jiang M.The long non-coding RNA-DANCR exerts oncogenic functions in non-small cell lung cancer via miR-758-3p[J].Biomed Pharmacotherapy,2018,103(16):94-100.
17 Zhen Q,Gao LN,Wang RF,et al.LncRNA DANCR promotes lung cancer by sequestering miR-216a[J].Cancer Control,2018,25(1):107-119.
18 Bai YZ,Chu GJ,He V,et al.The positive feedback loop of lncRNA DANCR/miR-138/Sox4 facilitates malignancy in non-small cell lung cancer[J].Am J Cancer Res,2019,9(2):270-284.
19 Guo L,Gu J,Hou S,et al.Long non-coding RNA DANCR promotes the progression of non-small-cell lung cancer by inhibiting p21 expression[J].Onco Targets Ther,2019,12(56):135-146.
20 Zhang N,Jiang W.Long noncoding RNA DANCR promotes HMGA2mediated invasion in lung adenocarcinoma cells[J].Oncol Rep,2019,41(2):1083-1090.
21 Ma X,Wang X,Yang C,et al.DANCR Acts as a diagnostic biomarker and promotes tumor growth and metastasis in hepatocellular carcinoma[J].Anticancer Res,2016,36(12):6389-6398.
22 Yuan SX,Wang J,Yang F,et al.Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepress ion of CTNNB1[J].Hepatology,2016,63(2):499-511.
23 Wang J,Pu J,Zhang Y,et al.DANCR contributed to hepatocellular carcinoma malignancy via sponging miR-216a-5p and modulating KLF12[J].J Cell Physio,2019,234(6):9408-9416.
24 Hao YP,Qiu JH,Zhang DB,et al.Long non-coding RNA DANCR,a prognostic indicator,promotes cell growth and tumorigenicity in gastric cancer[J].Tumor Biol,2017,39(6):101-118.
25 Mao Z,Li H,Du B,et al.LncRNA DANCR promotes migration and invasion through suppression of lncRNA-LET in gastric cancer cells[J].Biosci Rep,2017,37(6):122-132.
26 Pan L,Liang W,Gu JM,et al.Long noncoding RNA DANCR is activated by SALL4 and promotes the proliferation and invasion of gastric cancer cells[J].Oncotarget,2018,9(2):1915-1930.
27 Sha S,Yuan D,Liu Y,et al.Targeting long non-coding RNA DANCR inhibits triple negative breast cancer progression[J].Biol Open,2017,6(9):1310-1316.
28 Tang J,Zhong G,Zhang H,et al.LncRNA DANCR upregulates PI3K/AKT signaling through activating serine phosphorylation of RXRA[J].Cell Death Dis,2018,9(12):11-67.
29 Tao W,Wang C,Zhu B,et al.LncRNA DANCR contributes to tumor progression via targeting miR-216a-5p in breast cancer[J].Bioscience Reports,2019,9(12):101-126.
30 Vaidya AM,Sun Z,Ayat N,et al.Systemic delivery of tumor-targeting siRNA nanoparticles against an oncogenic LncRNA facilitates effective triple-negative breast cancer therapy[J].Bioconjug Chem,2019,30(3):907-919.
31 Cao L,Jin H,Zheng Y,et al.DANCR-mediated microRNA-665 regulates proliferation and metastasis of cervical cancer through the ERK/SMAD pathway[J].Cancer Sci,2019,110(3):913-925.
32 Liang H,Zhang C,Guan H,et al.LncRNA DANCR promotes cervical cancer progression by upregulating ROCK1 via sponging miR-335-5p[J].J Cell Physiol,2019,234(5):7266-7278.
33 Wang Y,Lu Z,Wang N,et al.Long noncoding RNA DANCR promotes colorectal cancer proliferation and metastasis via miR-577 sponging[J].Exp Mol Med,2018,50(5):57-67.
34 Yang XJ,Zhao JJ,Chen WJ,et al.Silencing long non-coding RNA,differentiation antagonizing non-protein coding RNA promotes apoptosis and inhibits tumor growth in colon cancer[J].Oncol Lett,2018,16(3):2865-2872.
35 Jia J,Li F,Tang XS,et al.Long noncoding RNA DANCR promotes invasion of prostate cancer through epigenetically silencing expression of TIMP/3[J].Oncotarget,2016,7(25):37868-37881.
36 Shi H,Shi J,Zhang Y,et al.Long non-coding RNA DANCR promotes cell proliferation,migration,invasion and resistance to apoptosis in esophageal cancer[J].J Thorac Dis,2018,10(5):2573-2582.
37 Chen L,Liu J,Tang T,et al.lncRNA differentiation antagonizing nonprotein coding RNA overexpression accelerates progression and indicates poor prognosis in pancreatic ductal adenocarcinoma[J].Onco Targets Ther,2018,11:7955-7965.
38 Zhang K,Lv J,Peng XW,et al.Downregulation of DANCR acts as a potential biomarker for papillary thyroid cancer diagnosis[J].Biosci Rep,2019,16(3):2865-2872.
39 Jin L,Fu H,Quan J,et al.Overexpression of long non-coding RNA differentiation antagonizing non-protein coding RNA inhibits the proliferation,migration and invasion and promotes apoptosis of renal cell carcinoma[J].Mol Med Rep,2017,16(4):4463-4468.
40 Villanueva A.Hepatocellular Carcinoma[J].N Engl J Med,2019,380(15):1450-1462.

[1]	周家琛, 郑荣寿, 庄贵华, 张思维, 曾红梅, 陈茹, 王少明, 孙可欣, 邹小农, 魏文强, 赫捷. 2000—2015年中国肿瘤登记地区胃癌发病趋势及年龄变化[J]. 实用肿瘤学杂志, 2020, 34(1): 1-5.
[2]	李春梅, 李幼飞, 贾红梅. 化疗联合手术治疗耐药性妊娠滋养细胞肿瘤的临床分析[J]. 实用肿瘤学杂志, 2020, 34(1): 55-59.
[3]	包乐, 唐丽萍. EphB6受体在恶性肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2020, 34(1): 83-87.
[4]	左志博, 郭志琴, 王振, 杨宏杰, 邬万新. Semaphorin 3F在肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2020, 34(1): 88-92.
[5]	刘耿淳, 申良方. 血清长链非编码RNA MALAT1和AFAP1-AS1与鼻咽癌临床病理特征和预后的关系[J]. 实用肿瘤学杂志, 2019, 33(6): 513-518.
[6]	李剑, 徐向英, 吕研. 局限期小细胞肺癌首程治疗失败后再程治疗的相关研究[J]. 实用肿瘤学杂志, 2019, 33(6): 519-524.
[7]	许健, 詹月萍, 蒋元烨, 曹勤. α-常春藤皂苷的抗肿瘤药理作用研究进展[J]. 实用肿瘤学杂志, 2019, 33(6): 553-556.
[8]	张慧婷, 娄阁. 卵巢癌肿瘤微环境的三维细胞培养模型研究进展[J]. 实用肿瘤学杂志, 2019, 33(6): 557-560.
[9]	李素素, 周春祥. NKT细胞对肝癌免疫应答的双向调控作用[J]. 实用肿瘤学杂志, 2019, 33(6): 540-543.
[10]	夏天一, 张博淼, 姚克非, 崔滨滨. PTPN9表达水平与结直肠癌的临床关系研究[J]. 实用肿瘤学杂志, 2019, 33(5): 415-419.
[11]	杨敏, 谢俊英, 谭培昭, 吴晓明, 于雷. 动态监测D-二聚体在肿瘤患者导管相关性血栓的临床意义[J]. 实用肿瘤学杂志, 2019, 33(5): 425-430.
[12]	黄显博, 史庭 , 叶琇锦. 靶向PI3K/AKT/mTOR信号通路治疗急性T淋巴细胞白血病的研究进展[J]. 实用肿瘤学杂志, 2019, 33(5): 451-455.
[13]	李亚飞, 张霄, 王雪飞, 翁明娇, 王天真. RNA结合蛋白Lin28在恶性肿瘤发生发展中的作用和分子机制[J]. 实用肿瘤学杂志, 2019, 33(5): 456-460.
[14]	王宇, 乔娟娟, 张磊, 刘四卫 , 杨树才. 类固醇激素在乳腺癌中的作用及对肿瘤干细胞的影响[J]. 实用肿瘤学杂志, 2019, 33(5): 466-470.
[15]	李思维 , 庞达. 长链非编码RNA(lncRNA)在癌症中的作用[J]. 实用肿瘤学杂志, 2019, 33(5): 471-475.